<code id='A60EB4BF3B'></code><style id='A60EB4BF3B'></style>
    • <acronym id='A60EB4BF3B'></acronym>
      <center id='A60EB4BF3B'><center id='A60EB4BF3B'><tfoot id='A60EB4BF3B'></tfoot></center><abbr id='A60EB4BF3B'><dir id='A60EB4BF3B'><tfoot id='A60EB4BF3B'></tfoot><noframes id='A60EB4BF3B'>

    • <optgroup id='A60EB4BF3B'><strike id='A60EB4BF3B'><sup id='A60EB4BF3B'></sup></strike><code id='A60EB4BF3B'></code></optgroup>
        1. <b id='A60EB4BF3B'><label id='A60EB4BF3B'><select id='A60EB4BF3B'><dt id='A60EB4BF3B'><span id='A60EB4BF3B'></span></dt></select></label></b><u id='A60EB4BF3B'></u>
          <i id='A60EB4BF3B'><strike id='A60EB4BF3B'><tt id='A60EB4BF3B'><pre id='A60EB4BF3B'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:75
          Two researchers look at a computer monitor showing a graph and other data
          Adobe

          Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

          Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

          advertisement

          The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Will the FTC rein in IQVIA's health data empire?
          Will the FTC rein in IQVIA's health data empire?

          AdobeThehealthdatagiantIQVIAbecameadominantforcebygobblingupitsrivals.Overdecades,itfeastedonupstart

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Senate panel puts off hardest PBM reforms for another day

          SenateFinanceCommitteeChairRonWyden(D-Ore.)LeahMillis/PoolviaAPWASHINGTON—SenatorsontheFinanceCommit